The most popular trade in equities is built on a forecast that history says you shouldn’t trust India’s small-cap universe has a problem. Consensus expects 35% of Nifty Small Cap 250 companies to deliver earnings growth of 30% or more over the next two years. The uncomfortable truth sitting rightContinue Reading

Jefferies warns structural shift will shrink managed services and increase cyclicality India’s information technology sector is experiencing its worst selloff in years, with the Nifty IT index plunging over 21% since January 1, 2026, erasing over Rs 1 lakh crore in market capitalization from the top five IT stocks alone.Continue Reading

The restructuring announcement revealed several factors that investors did not like, read on When a company announces a major restructuring and its stock falls 14% the same day, one of two things is true. Either the market misunderstood the deal. Or the market understood it perfectly. In UPL’s case, itContinue Reading

India’s offshore benchmark Gift Nifty clocks its highest-ever single-day trading value on Feb. 20 amid shifting US Trump Tariffs  GIFT Nifty recorded an all-time high single-day turnover of $23.48 billion on February 20, 2026, marking a milestone for India’s offshore derivatives market. Trading activity reached 457,989 contracts, surpassing the previousContinue Reading

Rural revival, GST cuts, and favorable commodity costs drive volume recovery;  but what next for stocks  The beleaguered fast-moving consumer goods sector is showing its first convincing signs of revival after years of volume stagnation, margin pressure, and rural demand weakness. But investors betting on the recovery may already beContinue Reading

Company acquires 55% stake in German heart device maker Occlutech Alkem Laboratories is acquiring up to 55% of German cardiovascular device specialist Occlutech for approximately EUR 99 million (Rs 1,060 crore) as it builds out a global MedTech business targeting Rs 15,000 crore in revenues within five years. The questionContinue Reading

Aerospace and energy component maker’s calibrated growth strategy and peak utilization by FY28 drive buy ratings despite near-term moderation, Q3 EBITDA margin hits 39.2% India’s deepening integration into global aerospace has driven Azad Engineering into the frontline. Brokerages are upgrading or maintaining buy ratings based on a Rs 6,500 croreContinue Reading